Clinical Trial Update: Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating telatinib added to capecitabine/oxaliplatin in first-line gastric or GEJ cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Telatinib (telatinib)

Snippet

Sponsor: Taizhou EOC Pharma Co., Ltd. | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN